Global Percutaneous Ventricular Assist Units Market Growth 2026-2032
The global Percutaneous Ventricular Assist Units market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
A percutaneous ventricular assist Units is a mechanical circulatory support device used to assist a weakened or failing heart by temporarily helping pump blood from the ventricles (lower chambers) of the heart to the rest of the body.
United States market for Percutaneous Ventricular Assist Units is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Percutaneous Ventricular Assist Units is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Percutaneous Ventricular Assist Units is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Percutaneous Ventricular Assist Units players cover Abiomed (Johnson & Johnson's), Supira Medical, Medtronic, Teleflex, LivaNova, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Percutaneous Ventricular Assist Units Industry Forecast? looks at past sales and reviews total world Percutaneous Ventricular Assist Units sales in 2025, providing a comprehensive analysis by region and market sector of projected Percutaneous Ventricular Assist Units sales for 2026 through 2032. With Percutaneous Ventricular Assist Units sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Percutaneous Ventricular Assist Units industry.
This Insight Report provides a comprehensive analysis of the global Percutaneous Ventricular Assist Units landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Percutaneous Ventricular Assist Units portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Percutaneous Ventricular Assist Units market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Percutaneous Ventricular Assist Units and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Percutaneous Ventricular Assist Units.
This report presents a comprehensive overview, market shares, and growth opportunities of Percutaneous Ventricular Assist Units market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
A percutaneous ventricular assist Units is a mechanical circulatory support device used to assist a weakened or failing heart by temporarily helping pump blood from the ventricles (lower chambers) of the heart to the rest of the body.
United States market for Percutaneous Ventricular Assist Units is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Percutaneous Ventricular Assist Units is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Percutaneous Ventricular Assist Units is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Percutaneous Ventricular Assist Units players cover Abiomed (Johnson & Johnson's), Supira Medical, Medtronic, Teleflex, LivaNova, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Percutaneous Ventricular Assist Units Industry Forecast? looks at past sales and reviews total world Percutaneous Ventricular Assist Units sales in 2025, providing a comprehensive analysis by region and market sector of projected Percutaneous Ventricular Assist Units sales for 2026 through 2032. With Percutaneous Ventricular Assist Units sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Percutaneous Ventricular Assist Units industry.
This Insight Report provides a comprehensive analysis of the global Percutaneous Ventricular Assist Units landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Percutaneous Ventricular Assist Units portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Percutaneous Ventricular Assist Units market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Percutaneous Ventricular Assist Units and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Percutaneous Ventricular Assist Units.
This report presents a comprehensive overview, market shares, and growth opportunities of Percutaneous Ventricular Assist Units market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Insertion Percutaneous Ventricular Assist Units
- Peripheral Percutaneous Ventricular Assist Units
- Hospital
- Institution
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abiomed (Johnson & Johnson's)
- Supira Medical
- Medtronic
- Teleflex
- LivaNova
- Berlin Heart GmbH
- What is the 10-year outlook for the global Percutaneous Ventricular Assist Units market?
- What factors are driving Percutaneous Ventricular Assist Units market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Percutaneous Ventricular Assist Units market opportunities vary by end market size?
- How does Percutaneous Ventricular Assist Units break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Percutaneous Ventricular Assist Units Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Percutaneous Ventricular Assist Units by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Percutaneous Ventricular Assist Units by Country/Region, 2021, 2025 & 2032
2.2 Percutaneous Ventricular Assist Units Segment by Type
2.2.1 Insertion Percutaneous Ventricular Assist Units
2.2.2 Peripheral Percutaneous Ventricular Assist Units
2.2.3 Percutaneous Ventricular Assist Units Sales by Type
2.2.3.1 Global Percutaneous Ventricular Assist Units Sales Market Share by Type (2021-2026)
2.2.3.2 Global Percutaneous Ventricular Assist Units Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Percutaneous Ventricular Assist Units Sale Price by Type (2021-2026)
2.3 Percutaneous Ventricular Assist Units Segment by Application
2.3.1 Hospital
2.3.2 Institution
2.3.3 Clinic
2.3.4 Others
2.3.5 Percutaneous Ventricular Assist Units Sales by Application
2.3.5.1 Global Percutaneous Ventricular Assist Units Sale Market Share by Application (2021-2026)
2.3.5.2 Global Percutaneous Ventricular Assist Units Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Percutaneous Ventricular Assist Units Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Percutaneous Ventricular Assist Units Breakdown Data by Company
3.1.1 Global Percutaneous Ventricular Assist Units Annual Sales by Company (2021-2026)
3.1.2 Global Percutaneous Ventricular Assist Units Sales Market Share by Company (2021-2026)
3.2 Global Percutaneous Ventricular Assist Units Annual Revenue by Company (2021-2026)
3.2.1 Global Percutaneous Ventricular Assist Units Revenue by Company (2021-2026)
3.2.2 Global Percutaneous Ventricular Assist Units Revenue Market Share by Company (2021-2026)
3.3 Global Percutaneous Ventricular Assist Units Sale Price by Company
3.4 Key Manufacturers Percutaneous Ventricular Assist Units Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Percutaneous Ventricular Assist Units Product Location Distribution
3.4.2 Players Percutaneous Ventricular Assist Units Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PERCUTANEOUS VENTRICULAR ASSIST UNITS BY GEOGRAPHIC REGION
4.1 World Historic Percutaneous Ventricular Assist Units Market Size by Geographic Region (2021-2026)
4.1.1 Global Percutaneous Ventricular Assist Units Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Percutaneous Ventricular Assist Units Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Percutaneous Ventricular Assist Units Market Size by Country/Region (2021-2026)
4.2.1 Global Percutaneous Ventricular Assist Units Annual Sales by Country/Region (2021-2026)
4.2.2 Global Percutaneous Ventricular Assist Units Annual Revenue by Country/Region (2021-2026)
4.3 Americas Percutaneous Ventricular Assist Units Sales Growth
4.4 APAC Percutaneous Ventricular Assist Units Sales Growth
4.5 Europe Percutaneous Ventricular Assist Units Sales Growth
4.6 Middle East & Africa Percutaneous Ventricular Assist Units Sales Growth
5 AMERICAS
5.1 Americas Percutaneous Ventricular Assist Units Sales by Country
5.1.1 Americas Percutaneous Ventricular Assist Units Sales by Country (2021-2026)
5.1.2 Americas Percutaneous Ventricular Assist Units Revenue by Country (2021-2026)
5.2 Americas Percutaneous Ventricular Assist Units Sales by Type (2021-2026)
5.3 Americas Percutaneous Ventricular Assist Units Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Percutaneous Ventricular Assist Units Sales by Region
6.1.1 APAC Percutaneous Ventricular Assist Units Sales by Region (2021-2026)
6.1.2 APAC Percutaneous Ventricular Assist Units Revenue by Region (2021-2026)
6.2 APAC Percutaneous Ventricular Assist Units Sales by Type (2021-2026)
6.3 APAC Percutaneous Ventricular Assist Units Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Percutaneous Ventricular Assist Units by Country
7.1.1 Europe Percutaneous Ventricular Assist Units Sales by Country (2021-2026)
7.1.2 Europe Percutaneous Ventricular Assist Units Revenue by Country (2021-2026)
7.2 Europe Percutaneous Ventricular Assist Units Sales by Type (2021-2026)
7.3 Europe Percutaneous Ventricular Assist Units Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Percutaneous Ventricular Assist Units by Country
8.1.1 Middle East & Africa Percutaneous Ventricular Assist Units Sales by Country (2021-2026)
8.1.2 Middle East & Africa Percutaneous Ventricular Assist Units Revenue by Country (2021-2026)
8.2 Middle East & Africa Percutaneous Ventricular Assist Units Sales by Type (2021-2026)
8.3 Middle East & Africa Percutaneous Ventricular Assist Units Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Percutaneous Ventricular Assist Units
10.3 Manufacturing Process Analysis of Percutaneous Ventricular Assist Units
10.4 Industry Chain Structure of Percutaneous Ventricular Assist Units
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Percutaneous Ventricular Assist Units Distributors
11.3 Percutaneous Ventricular Assist Units Customer
12 WORLD FORECAST REVIEW FOR PERCUTANEOUS VENTRICULAR ASSIST UNITS BY GEOGRAPHIC REGION
12.1 Global Percutaneous Ventricular Assist Units Market Size Forecast by Region
12.1.1 Global Percutaneous Ventricular Assist Units Forecast by Region (2027-2032)
12.1.2 Global Percutaneous Ventricular Assist Units Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Percutaneous Ventricular Assist Units Forecast by Type (2027-2032)
12.7 Global Percutaneous Ventricular Assist Units Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Abiomed (Johnson & Johnson's)
13.1.1 Abiomed (Johnson & Johnson's) Company Information
13.1.2 Abiomed (Johnson & Johnson's) Percutaneous Ventricular Assist Units Product Portfolios and Specifications
13.1.3 Abiomed (Johnson & Johnson's) Percutaneous Ventricular Assist Units Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Abiomed (Johnson & Johnson's) Main Business Overview
13.1.5 Abiomed (Johnson & Johnson's) Latest Developments
13.2 Supira Medical
13.2.1 Supira Medical Company Information
13.2.2 Supira Medical Percutaneous Ventricular Assist Units Product Portfolios and Specifications
13.2.3 Supira Medical Percutaneous Ventricular Assist Units Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Supira Medical Main Business Overview
13.2.5 Supira Medical Latest Developments
13.3 Medtronic
13.3.1 Medtronic Company Information
13.3.2 Medtronic Percutaneous Ventricular Assist Units Product Portfolios and Specifications
13.3.3 Medtronic Percutaneous Ventricular Assist Units Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Medtronic Main Business Overview
13.3.5 Medtronic Latest Developments
13.4 Teleflex
13.4.1 Teleflex Company Information
13.4.2 Teleflex Percutaneous Ventricular Assist Units Product Portfolios and Specifications
13.4.3 Teleflex Percutaneous Ventricular Assist Units Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Teleflex Main Business Overview
13.4.5 Teleflex Latest Developments
13.5 LivaNova
13.5.1 LivaNova Company Information
13.5.2 LivaNova Percutaneous Ventricular Assist Units Product Portfolios and Specifications
13.5.3 LivaNova Percutaneous Ventricular Assist Units Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 LivaNova Main Business Overview
13.5.5 LivaNova Latest Developments
13.6 Berlin Heart GmbH
13.6.1 Berlin Heart GmbH Company Information
13.6.2 Berlin Heart GmbH Percutaneous Ventricular Assist Units Product Portfolios and Specifications
13.6.3 Berlin Heart GmbH Percutaneous Ventricular Assist Units Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Berlin Heart GmbH Main Business Overview
13.6.5 Berlin Heart GmbH Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Percutaneous Ventricular Assist Units Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Percutaneous Ventricular Assist Units by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Percutaneous Ventricular Assist Units by Country/Region, 2021, 2025 & 2032
2.2 Percutaneous Ventricular Assist Units Segment by Type
2.2.1 Insertion Percutaneous Ventricular Assist Units
2.2.2 Peripheral Percutaneous Ventricular Assist Units
2.2.3 Percutaneous Ventricular Assist Units Sales by Type
2.2.3.1 Global Percutaneous Ventricular Assist Units Sales Market Share by Type (2021-2026)
2.2.3.2 Global Percutaneous Ventricular Assist Units Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Percutaneous Ventricular Assist Units Sale Price by Type (2021-2026)
2.3 Percutaneous Ventricular Assist Units Segment by Application
2.3.1 Hospital
2.3.2 Institution
2.3.3 Clinic
2.3.4 Others
2.3.5 Percutaneous Ventricular Assist Units Sales by Application
2.3.5.1 Global Percutaneous Ventricular Assist Units Sale Market Share by Application (2021-2026)
2.3.5.2 Global Percutaneous Ventricular Assist Units Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Percutaneous Ventricular Assist Units Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Percutaneous Ventricular Assist Units Breakdown Data by Company
3.1.1 Global Percutaneous Ventricular Assist Units Annual Sales by Company (2021-2026)
3.1.2 Global Percutaneous Ventricular Assist Units Sales Market Share by Company (2021-2026)
3.2 Global Percutaneous Ventricular Assist Units Annual Revenue by Company (2021-2026)
3.2.1 Global Percutaneous Ventricular Assist Units Revenue by Company (2021-2026)
3.2.2 Global Percutaneous Ventricular Assist Units Revenue Market Share by Company (2021-2026)
3.3 Global Percutaneous Ventricular Assist Units Sale Price by Company
3.4 Key Manufacturers Percutaneous Ventricular Assist Units Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Percutaneous Ventricular Assist Units Product Location Distribution
3.4.2 Players Percutaneous Ventricular Assist Units Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PERCUTANEOUS VENTRICULAR ASSIST UNITS BY GEOGRAPHIC REGION
4.1 World Historic Percutaneous Ventricular Assist Units Market Size by Geographic Region (2021-2026)
4.1.1 Global Percutaneous Ventricular Assist Units Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Percutaneous Ventricular Assist Units Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Percutaneous Ventricular Assist Units Market Size by Country/Region (2021-2026)
4.2.1 Global Percutaneous Ventricular Assist Units Annual Sales by Country/Region (2021-2026)
4.2.2 Global Percutaneous Ventricular Assist Units Annual Revenue by Country/Region (2021-2026)
4.3 Americas Percutaneous Ventricular Assist Units Sales Growth
4.4 APAC Percutaneous Ventricular Assist Units Sales Growth
4.5 Europe Percutaneous Ventricular Assist Units Sales Growth
4.6 Middle East & Africa Percutaneous Ventricular Assist Units Sales Growth
5 AMERICAS
5.1 Americas Percutaneous Ventricular Assist Units Sales by Country
5.1.1 Americas Percutaneous Ventricular Assist Units Sales by Country (2021-2026)
5.1.2 Americas Percutaneous Ventricular Assist Units Revenue by Country (2021-2026)
5.2 Americas Percutaneous Ventricular Assist Units Sales by Type (2021-2026)
5.3 Americas Percutaneous Ventricular Assist Units Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Percutaneous Ventricular Assist Units Sales by Region
6.1.1 APAC Percutaneous Ventricular Assist Units Sales by Region (2021-2026)
6.1.2 APAC Percutaneous Ventricular Assist Units Revenue by Region (2021-2026)
6.2 APAC Percutaneous Ventricular Assist Units Sales by Type (2021-2026)
6.3 APAC Percutaneous Ventricular Assist Units Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Percutaneous Ventricular Assist Units by Country
7.1.1 Europe Percutaneous Ventricular Assist Units Sales by Country (2021-2026)
7.1.2 Europe Percutaneous Ventricular Assist Units Revenue by Country (2021-2026)
7.2 Europe Percutaneous Ventricular Assist Units Sales by Type (2021-2026)
7.3 Europe Percutaneous Ventricular Assist Units Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Percutaneous Ventricular Assist Units by Country
8.1.1 Middle East & Africa Percutaneous Ventricular Assist Units Sales by Country (2021-2026)
8.1.2 Middle East & Africa Percutaneous Ventricular Assist Units Revenue by Country (2021-2026)
8.2 Middle East & Africa Percutaneous Ventricular Assist Units Sales by Type (2021-2026)
8.3 Middle East & Africa Percutaneous Ventricular Assist Units Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Percutaneous Ventricular Assist Units
10.3 Manufacturing Process Analysis of Percutaneous Ventricular Assist Units
10.4 Industry Chain Structure of Percutaneous Ventricular Assist Units
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Percutaneous Ventricular Assist Units Distributors
11.3 Percutaneous Ventricular Assist Units Customer
12 WORLD FORECAST REVIEW FOR PERCUTANEOUS VENTRICULAR ASSIST UNITS BY GEOGRAPHIC REGION
12.1 Global Percutaneous Ventricular Assist Units Market Size Forecast by Region
12.1.1 Global Percutaneous Ventricular Assist Units Forecast by Region (2027-2032)
12.1.2 Global Percutaneous Ventricular Assist Units Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Percutaneous Ventricular Assist Units Forecast by Type (2027-2032)
12.7 Global Percutaneous Ventricular Assist Units Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Abiomed (Johnson & Johnson's)
13.1.1 Abiomed (Johnson & Johnson's) Company Information
13.1.2 Abiomed (Johnson & Johnson's) Percutaneous Ventricular Assist Units Product Portfolios and Specifications
13.1.3 Abiomed (Johnson & Johnson's) Percutaneous Ventricular Assist Units Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Abiomed (Johnson & Johnson's) Main Business Overview
13.1.5 Abiomed (Johnson & Johnson's) Latest Developments
13.2 Supira Medical
13.2.1 Supira Medical Company Information
13.2.2 Supira Medical Percutaneous Ventricular Assist Units Product Portfolios and Specifications
13.2.3 Supira Medical Percutaneous Ventricular Assist Units Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Supira Medical Main Business Overview
13.2.5 Supira Medical Latest Developments
13.3 Medtronic
13.3.1 Medtronic Company Information
13.3.2 Medtronic Percutaneous Ventricular Assist Units Product Portfolios and Specifications
13.3.3 Medtronic Percutaneous Ventricular Assist Units Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Medtronic Main Business Overview
13.3.5 Medtronic Latest Developments
13.4 Teleflex
13.4.1 Teleflex Company Information
13.4.2 Teleflex Percutaneous Ventricular Assist Units Product Portfolios and Specifications
13.4.3 Teleflex Percutaneous Ventricular Assist Units Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Teleflex Main Business Overview
13.4.5 Teleflex Latest Developments
13.5 LivaNova
13.5.1 LivaNova Company Information
13.5.2 LivaNova Percutaneous Ventricular Assist Units Product Portfolios and Specifications
13.5.3 LivaNova Percutaneous Ventricular Assist Units Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 LivaNova Main Business Overview
13.5.5 LivaNova Latest Developments
13.6 Berlin Heart GmbH
13.6.1 Berlin Heart GmbH Company Information
13.6.2 Berlin Heart GmbH Percutaneous Ventricular Assist Units Product Portfolios and Specifications
13.6.3 Berlin Heart GmbH Percutaneous Ventricular Assist Units Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Berlin Heart GmbH Main Business Overview
13.6.5 Berlin Heart GmbH Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Percutaneous Ventricular Assist Units Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Percutaneous Ventricular Assist Units Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Insertion Percutaneous Ventricular Assist Units
Table 4. Major Players of Peripheral Percutaneous Ventricular Assist Units
Table 5. Global Percutaneous Ventricular Assist Units Sales by Type (2021-2026) & (K Units)
Table 6. Global Percutaneous Ventricular Assist Units Sales Market Share by Type (2021-2026)
Table 7. Global Percutaneous Ventricular Assist Units Revenue by Type (2021-2026) & ($ million)
Table 8. Global Percutaneous Ventricular Assist Units Revenue Market Share by Type (2021-2026)
Table 9. Global Percutaneous Ventricular Assist Units Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Percutaneous Ventricular Assist Units Sale by Application (2021-2026) & (K Units)
Table 11. Global Percutaneous Ventricular Assist Units Sale Market Share by Application (2021-2026)
Table 12. Global Percutaneous Ventricular Assist Units Revenue by Application (2021-2026) & ($ million)
Table 13. Global Percutaneous Ventricular Assist Units Revenue Market Share by Application (2021-2026)
Table 14. Global Percutaneous Ventricular Assist Units Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Percutaneous Ventricular Assist Units Sales by Company (2021-2026) & (K Units)
Table 16. Global Percutaneous Ventricular Assist Units Sales Market Share by Company (2021-2026)
Table 17. Global Percutaneous Ventricular Assist Units Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Percutaneous Ventricular Assist Units Revenue Market Share by Company (2021-2026)
Table 19. Global Percutaneous Ventricular Assist Units Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Percutaneous Ventricular Assist Units Producing Area Distribution and Sales Area
Table 21. Players Percutaneous Ventricular Assist Units Products Offered
Table 22. Percutaneous Ventricular Assist Units Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Percutaneous Ventricular Assist Units Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Percutaneous Ventricular Assist Units Sales Market Share Geographic Region (2021-2026)
Table 27. Global Percutaneous Ventricular Assist Units Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Percutaneous Ventricular Assist Units Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Percutaneous Ventricular Assist Units Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Percutaneous Ventricular Assist Units Sales Market Share by Country/Region (2021-2026)
Table 31. Global Percutaneous Ventricular Assist Units Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Percutaneous Ventricular Assist Units Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Percutaneous Ventricular Assist Units Sales by Country (2021-2026) & (K Units)
Table 34. Americas Percutaneous Ventricular Assist Units Sales Market Share by Country (2021-2026)
Table 35. Americas Percutaneous Ventricular Assist Units Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Percutaneous Ventricular Assist Units Sales by Type (2021-2026) & (K Units)
Table 37. Americas Percutaneous Ventricular Assist Units Sales by Application (2021-2026) & (K Units)
Table 38. APAC Percutaneous Ventricular Assist Units Sales by Region (2021-2026) & (K Units)
Table 39. APAC Percutaneous Ventricular Assist Units Sales Market Share by Region (2021-2026)
Table 40. APAC Percutaneous Ventricular Assist Units Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Percutaneous Ventricular Assist Units Sales by Type (2021-2026) & (K Units)
Table 42. APAC Percutaneous Ventricular Assist Units Sales by Application (2021-2026) & (K Units)
Table 43. Europe Percutaneous Ventricular Assist Units Sales by Country (2021-2026) & (K Units)
Table 44. Europe Percutaneous Ventricular Assist Units Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Percutaneous Ventricular Assist Units Sales by Type (2021-2026) & (K Units)
Table 46. Europe Percutaneous Ventricular Assist Units Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Percutaneous Ventricular Assist Units Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Percutaneous Ventricular Assist Units Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Percutaneous Ventricular Assist Units Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Percutaneous Ventricular Assist Units Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Percutaneous Ventricular Assist Units
Table 52. Key Market Challenges & Risks of Percutaneous Ventricular Assist Units
Table 53. Key Industry Trends of Percutaneous Ventricular Assist Units
Table 54. Percutaneous Ventricular Assist Units Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Percutaneous Ventricular Assist Units Distributors List
Table 57. Percutaneous Ventricular Assist Units Customer List
Table 58. Global Percutaneous Ventricular Assist Units Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Percutaneous Ventricular Assist Units Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Percutaneous Ventricular Assist Units Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Percutaneous Ventricular Assist Units Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Percutaneous Ventricular Assist Units Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Percutaneous Ventricular Assist Units Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Percutaneous Ventricular Assist Units Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Percutaneous Ventricular Assist Units Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Percutaneous Ventricular Assist Units Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Percutaneous Ventricular Assist Units Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Percutaneous Ventricular Assist Units Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Percutaneous Ventricular Assist Units Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Percutaneous Ventricular Assist Units Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Percutaneous Ventricular Assist Units Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Abiomed (Johnson & Johnson's) Basic Information, Percutaneous Ventricular Assist Units Manufacturing Base, Sales Area and Its Competitors
Table 73. Abiomed (Johnson & Johnson's) Percutaneous Ventricular Assist Units Product Portfolios and Specifications
Table 74. Abiomed (Johnson & Johnson's) Percutaneous Ventricular Assist Units Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Abiomed (Johnson & Johnson's) Main Business
Table 76. Abiomed (Johnson & Johnson's) Latest Developments
Table 77. Supira Medical Basic Information, Percutaneous Ventricular Assist Units Manufacturing Base, Sales Area and Its Competitors
Table 78. Supira Medical Percutaneous Ventricular Assist Units Product Portfolios and Specifications
Table 79. Supira Medical Percutaneous Ventricular Assist Units Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Supira Medical Main Business
Table 81. Supira Medical Latest Developments
Table 82. Medtronic Basic Information, Percutaneous Ventricular Assist Units Manufacturing Base, Sales Area and Its Competitors
Table 83. Medtronic Percutaneous Ventricular Assist Units Product Portfolios and Specifications
Table 84. Medtronic Percutaneous Ventricular Assist Units Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Medtronic Main Business
Table 86. Medtronic Latest Developments
Table 87. Teleflex Basic Information, Percutaneous Ventricular Assist Units Manufacturing Base, Sales Area and Its Competitors
Table 88. Teleflex Percutaneous Ventricular Assist Units Product Portfolios and Specifications
Table 89. Teleflex Percutaneous Ventricular Assist Units Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Teleflex Main Business
Table 91. Teleflex Latest Developments
Table 92. LivaNova Basic Information, Percutaneous Ventricular Assist Units Manufacturing Base, Sales Area and Its Competitors
Table 93. LivaNova Percutaneous Ventricular Assist Units Product Portfolios and Specifications
Table 94. LivaNova Percutaneous Ventricular Assist Units Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. LivaNova Main Business
Table 96. LivaNova Latest Developments
Table 97. Berlin Heart GmbH Basic Information, Percutaneous Ventricular Assist Units Manufacturing Base, Sales Area and Its Competitors
Table 98. Berlin Heart GmbH Percutaneous Ventricular Assist Units Product Portfolios and Specifications
Table 99. Berlin Heart GmbH Percutaneous Ventricular Assist Units Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Berlin Heart GmbH Main Business
Table 101. Berlin Heart GmbH Latest Developments
Table 1. Percutaneous Ventricular Assist Units Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Percutaneous Ventricular Assist Units Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Insertion Percutaneous Ventricular Assist Units
Table 4. Major Players of Peripheral Percutaneous Ventricular Assist Units
Table 5. Global Percutaneous Ventricular Assist Units Sales by Type (2021-2026) & (K Units)
Table 6. Global Percutaneous Ventricular Assist Units Sales Market Share by Type (2021-2026)
Table 7. Global Percutaneous Ventricular Assist Units Revenue by Type (2021-2026) & ($ million)
Table 8. Global Percutaneous Ventricular Assist Units Revenue Market Share by Type (2021-2026)
Table 9. Global Percutaneous Ventricular Assist Units Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Percutaneous Ventricular Assist Units Sale by Application (2021-2026) & (K Units)
Table 11. Global Percutaneous Ventricular Assist Units Sale Market Share by Application (2021-2026)
Table 12. Global Percutaneous Ventricular Assist Units Revenue by Application (2021-2026) & ($ million)
Table 13. Global Percutaneous Ventricular Assist Units Revenue Market Share by Application (2021-2026)
Table 14. Global Percutaneous Ventricular Assist Units Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Percutaneous Ventricular Assist Units Sales by Company (2021-2026) & (K Units)
Table 16. Global Percutaneous Ventricular Assist Units Sales Market Share by Company (2021-2026)
Table 17. Global Percutaneous Ventricular Assist Units Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Percutaneous Ventricular Assist Units Revenue Market Share by Company (2021-2026)
Table 19. Global Percutaneous Ventricular Assist Units Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Percutaneous Ventricular Assist Units Producing Area Distribution and Sales Area
Table 21. Players Percutaneous Ventricular Assist Units Products Offered
Table 22. Percutaneous Ventricular Assist Units Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Percutaneous Ventricular Assist Units Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Percutaneous Ventricular Assist Units Sales Market Share Geographic Region (2021-2026)
Table 27. Global Percutaneous Ventricular Assist Units Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Percutaneous Ventricular Assist Units Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Percutaneous Ventricular Assist Units Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Percutaneous Ventricular Assist Units Sales Market Share by Country/Region (2021-2026)
Table 31. Global Percutaneous Ventricular Assist Units Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Percutaneous Ventricular Assist Units Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Percutaneous Ventricular Assist Units Sales by Country (2021-2026) & (K Units)
Table 34. Americas Percutaneous Ventricular Assist Units Sales Market Share by Country (2021-2026)
Table 35. Americas Percutaneous Ventricular Assist Units Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Percutaneous Ventricular Assist Units Sales by Type (2021-2026) & (K Units)
Table 37. Americas Percutaneous Ventricular Assist Units Sales by Application (2021-2026) & (K Units)
Table 38. APAC Percutaneous Ventricular Assist Units Sales by Region (2021-2026) & (K Units)
Table 39. APAC Percutaneous Ventricular Assist Units Sales Market Share by Region (2021-2026)
Table 40. APAC Percutaneous Ventricular Assist Units Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Percutaneous Ventricular Assist Units Sales by Type (2021-2026) & (K Units)
Table 42. APAC Percutaneous Ventricular Assist Units Sales by Application (2021-2026) & (K Units)
Table 43. Europe Percutaneous Ventricular Assist Units Sales by Country (2021-2026) & (K Units)
Table 44. Europe Percutaneous Ventricular Assist Units Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Percutaneous Ventricular Assist Units Sales by Type (2021-2026) & (K Units)
Table 46. Europe Percutaneous Ventricular Assist Units Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Percutaneous Ventricular Assist Units Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Percutaneous Ventricular Assist Units Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Percutaneous Ventricular Assist Units Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Percutaneous Ventricular Assist Units Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Percutaneous Ventricular Assist Units
Table 52. Key Market Challenges & Risks of Percutaneous Ventricular Assist Units
Table 53. Key Industry Trends of Percutaneous Ventricular Assist Units
Table 54. Percutaneous Ventricular Assist Units Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Percutaneous Ventricular Assist Units Distributors List
Table 57. Percutaneous Ventricular Assist Units Customer List
Table 58. Global Percutaneous Ventricular Assist Units Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Percutaneous Ventricular Assist Units Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Percutaneous Ventricular Assist Units Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Percutaneous Ventricular Assist Units Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Percutaneous Ventricular Assist Units Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Percutaneous Ventricular Assist Units Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Percutaneous Ventricular Assist Units Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Percutaneous Ventricular Assist Units Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Percutaneous Ventricular Assist Units Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Percutaneous Ventricular Assist Units Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Percutaneous Ventricular Assist Units Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Percutaneous Ventricular Assist Units Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Percutaneous Ventricular Assist Units Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Percutaneous Ventricular Assist Units Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Abiomed (Johnson & Johnson's) Basic Information, Percutaneous Ventricular Assist Units Manufacturing Base, Sales Area and Its Competitors
Table 73. Abiomed (Johnson & Johnson's) Percutaneous Ventricular Assist Units Product Portfolios and Specifications
Table 74. Abiomed (Johnson & Johnson's) Percutaneous Ventricular Assist Units Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Abiomed (Johnson & Johnson's) Main Business
Table 76. Abiomed (Johnson & Johnson's) Latest Developments
Table 77. Supira Medical Basic Information, Percutaneous Ventricular Assist Units Manufacturing Base, Sales Area and Its Competitors
Table 78. Supira Medical Percutaneous Ventricular Assist Units Product Portfolios and Specifications
Table 79. Supira Medical Percutaneous Ventricular Assist Units Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Supira Medical Main Business
Table 81. Supira Medical Latest Developments
Table 82. Medtronic Basic Information, Percutaneous Ventricular Assist Units Manufacturing Base, Sales Area and Its Competitors
Table 83. Medtronic Percutaneous Ventricular Assist Units Product Portfolios and Specifications
Table 84. Medtronic Percutaneous Ventricular Assist Units Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Medtronic Main Business
Table 86. Medtronic Latest Developments
Table 87. Teleflex Basic Information, Percutaneous Ventricular Assist Units Manufacturing Base, Sales Area and Its Competitors
Table 88. Teleflex Percutaneous Ventricular Assist Units Product Portfolios and Specifications
Table 89. Teleflex Percutaneous Ventricular Assist Units Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Teleflex Main Business
Table 91. Teleflex Latest Developments
Table 92. LivaNova Basic Information, Percutaneous Ventricular Assist Units Manufacturing Base, Sales Area and Its Competitors
Table 93. LivaNova Percutaneous Ventricular Assist Units Product Portfolios and Specifications
Table 94. LivaNova Percutaneous Ventricular Assist Units Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. LivaNova Main Business
Table 96. LivaNova Latest Developments
Table 97. Berlin Heart GmbH Basic Information, Percutaneous Ventricular Assist Units Manufacturing Base, Sales Area and Its Competitors
Table 98. Berlin Heart GmbH Percutaneous Ventricular Assist Units Product Portfolios and Specifications
Table 99. Berlin Heart GmbH Percutaneous Ventricular Assist Units Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Berlin Heart GmbH Main Business
Table 101. Berlin Heart GmbH Latest Developments
LIST OF FIGURES
Figure 1. Picture of Percutaneous Ventricular Assist Units
Figure 2. Percutaneous Ventricular Assist Units Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Percutaneous Ventricular Assist Units Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Percutaneous Ventricular Assist Units Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Percutaneous Ventricular Assist Units Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Percutaneous Ventricular Assist Units Sales Market Share by Country/Region (2025)
Figure 10. Percutaneous Ventricular Assist Units Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Insertion Percutaneous Ventricular Assist Units
Figure 12. Product Picture of Peripheral Percutaneous Ventricular Assist Units
Figure 13. Global Percutaneous Ventricular Assist Units Sales Market Share by Type in 2026
Figure 14. Global Percutaneous Ventricular Assist Units Revenue Market Share by Type (2021-2026)
Figure 15. Percutaneous Ventricular Assist Units Consumed in Hospital
Figure 16. Global Percutaneous Ventricular Assist Units Market: Hospital (2021-2026) & (K Units)
Figure 17. Percutaneous Ventricular Assist Units Consumed in Institution
Figure 18. Global Percutaneous Ventricular Assist Units Market: Institution (2021-2026) & (K Units)
Figure 19. Percutaneous Ventricular Assist Units Consumed in Clinic
Figure 20. Global Percutaneous Ventricular Assist Units Market: Clinic (2021-2026) & (K Units)
Figure 21. Percutaneous Ventricular Assist Units Consumed in Others
Figure 22. Global Percutaneous Ventricular Assist Units Market: Others (2021-2026) & (K Units)
Figure 23. Global Percutaneous Ventricular Assist Units Sale Market Share by Application (2025)
Figure 24. Global Percutaneous Ventricular Assist Units Revenue Market Share by Application in 2026
Figure 25. Percutaneous Ventricular Assist Units Sales by Company in 2026 (K Units)
Figure 26. Global Percutaneous Ventricular Assist Units Sales Market Share by Company in 2026
Figure 27. Percutaneous Ventricular Assist Units Revenue by Company in 2026 ($ millions)
Figure 28. Global Percutaneous Ventricular Assist Units Revenue Market Share by Company in 2026
Figure 29. Global Percutaneous Ventricular Assist Units Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Percutaneous Ventricular Assist Units Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Percutaneous Ventricular Assist Units Sales 2021-2026 (K Units)
Figure 32. Americas Percutaneous Ventricular Assist Units Revenue 2021-2026 ($ millions)
Figure 33. APAC Percutaneous Ventricular Assist Units Sales 2021-2026 (K Units)
Figure 34. APAC Percutaneous Ventricular Assist Units Revenue 2021-2026 ($ millions)
Figure 35. Europe Percutaneous Ventricular Assist Units Sales 2021-2026 (K Units)
Figure 36. Europe Percutaneous Ventricular Assist Units Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Percutaneous Ventricular Assist Units Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Percutaneous Ventricular Assist Units Revenue 2021-2026 ($ millions)
Figure 39. Americas Percutaneous Ventricular Assist Units Sales Market Share by Country in 2026
Figure 40. Americas Percutaneous Ventricular Assist Units Revenue Market Share by Country (2021-2026)
Figure 41. Americas Percutaneous Ventricular Assist Units Sales Market Share by Type (2021-2026)
Figure 42. Americas Percutaneous Ventricular Assist Units Sales Market Share by Application (2021-2026)
Figure 43. United States Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Percutaneous Ventricular Assist Units Sales Market Share by Region in 2026
Figure 48. APAC Percutaneous Ventricular Assist Units Revenue Market Share by Region (2021-2026)
Figure 49. APAC Percutaneous Ventricular Assist Units Sales Market Share by Type (2021-2026)
Figure 50. APAC Percutaneous Ventricular Assist Units Sales Market Share by Application (2021-2026)
Figure 51. China Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 55. India Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Percutaneous Ventricular Assist Units Sales Market Share by Country in 2026
Figure 59. Europe Percutaneous Ventricular Assist Units Revenue Market Share by Country (2021-2026)
Figure 60. Europe Percutaneous Ventricular Assist Units Sales Market Share by Type (2021-2026)
Figure 61. Europe Percutaneous Ventricular Assist Units Sales Market Share by Application (2021-2026)
Figure 62. Germany Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 63. France Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Percutaneous Ventricular Assist Units Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Percutaneous Ventricular Assist Units Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Percutaneous Ventricular Assist Units Sales Market Share by Application (2021-2026)
Figure 70. Egypt Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Percutaneous Ventricular Assist Units in 2026
Figure 76. Manufacturing Process Analysis of Percutaneous Ventricular Assist Units
Figure 77. Industry Chain Structure of Percutaneous Ventricular Assist Units
Figure 78. Channels of Distribution
Figure 79. Global Percutaneous Ventricular Assist Units Sales Market Forecast by Region (2027-2032)
Figure 80. Global Percutaneous Ventricular Assist Units Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Percutaneous Ventricular Assist Units Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Percutaneous Ventricular Assist Units Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Percutaneous Ventricular Assist Units Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Percutaneous Ventricular Assist Units Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Percutaneous Ventricular Assist Units
Figure 2. Percutaneous Ventricular Assist Units Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Percutaneous Ventricular Assist Units Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Percutaneous Ventricular Assist Units Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Percutaneous Ventricular Assist Units Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Percutaneous Ventricular Assist Units Sales Market Share by Country/Region (2025)
Figure 10. Percutaneous Ventricular Assist Units Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Insertion Percutaneous Ventricular Assist Units
Figure 12. Product Picture of Peripheral Percutaneous Ventricular Assist Units
Figure 13. Global Percutaneous Ventricular Assist Units Sales Market Share by Type in 2026
Figure 14. Global Percutaneous Ventricular Assist Units Revenue Market Share by Type (2021-2026)
Figure 15. Percutaneous Ventricular Assist Units Consumed in Hospital
Figure 16. Global Percutaneous Ventricular Assist Units Market: Hospital (2021-2026) & (K Units)
Figure 17. Percutaneous Ventricular Assist Units Consumed in Institution
Figure 18. Global Percutaneous Ventricular Assist Units Market: Institution (2021-2026) & (K Units)
Figure 19. Percutaneous Ventricular Assist Units Consumed in Clinic
Figure 20. Global Percutaneous Ventricular Assist Units Market: Clinic (2021-2026) & (K Units)
Figure 21. Percutaneous Ventricular Assist Units Consumed in Others
Figure 22. Global Percutaneous Ventricular Assist Units Market: Others (2021-2026) & (K Units)
Figure 23. Global Percutaneous Ventricular Assist Units Sale Market Share by Application (2025)
Figure 24. Global Percutaneous Ventricular Assist Units Revenue Market Share by Application in 2026
Figure 25. Percutaneous Ventricular Assist Units Sales by Company in 2026 (K Units)
Figure 26. Global Percutaneous Ventricular Assist Units Sales Market Share by Company in 2026
Figure 27. Percutaneous Ventricular Assist Units Revenue by Company in 2026 ($ millions)
Figure 28. Global Percutaneous Ventricular Assist Units Revenue Market Share by Company in 2026
Figure 29. Global Percutaneous Ventricular Assist Units Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Percutaneous Ventricular Assist Units Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Percutaneous Ventricular Assist Units Sales 2021-2026 (K Units)
Figure 32. Americas Percutaneous Ventricular Assist Units Revenue 2021-2026 ($ millions)
Figure 33. APAC Percutaneous Ventricular Assist Units Sales 2021-2026 (K Units)
Figure 34. APAC Percutaneous Ventricular Assist Units Revenue 2021-2026 ($ millions)
Figure 35. Europe Percutaneous Ventricular Assist Units Sales 2021-2026 (K Units)
Figure 36. Europe Percutaneous Ventricular Assist Units Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Percutaneous Ventricular Assist Units Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Percutaneous Ventricular Assist Units Revenue 2021-2026 ($ millions)
Figure 39. Americas Percutaneous Ventricular Assist Units Sales Market Share by Country in 2026
Figure 40. Americas Percutaneous Ventricular Assist Units Revenue Market Share by Country (2021-2026)
Figure 41. Americas Percutaneous Ventricular Assist Units Sales Market Share by Type (2021-2026)
Figure 42. Americas Percutaneous Ventricular Assist Units Sales Market Share by Application (2021-2026)
Figure 43. United States Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Percutaneous Ventricular Assist Units Sales Market Share by Region in 2026
Figure 48. APAC Percutaneous Ventricular Assist Units Revenue Market Share by Region (2021-2026)
Figure 49. APAC Percutaneous Ventricular Assist Units Sales Market Share by Type (2021-2026)
Figure 50. APAC Percutaneous Ventricular Assist Units Sales Market Share by Application (2021-2026)
Figure 51. China Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 55. India Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Percutaneous Ventricular Assist Units Sales Market Share by Country in 2026
Figure 59. Europe Percutaneous Ventricular Assist Units Revenue Market Share by Country (2021-2026)
Figure 60. Europe Percutaneous Ventricular Assist Units Sales Market Share by Type (2021-2026)
Figure 61. Europe Percutaneous Ventricular Assist Units Sales Market Share by Application (2021-2026)
Figure 62. Germany Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 63. France Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Percutaneous Ventricular Assist Units Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Percutaneous Ventricular Assist Units Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Percutaneous Ventricular Assist Units Sales Market Share by Application (2021-2026)
Figure 70. Egypt Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Percutaneous Ventricular Assist Units Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Percutaneous Ventricular Assist Units in 2026
Figure 76. Manufacturing Process Analysis of Percutaneous Ventricular Assist Units
Figure 77. Industry Chain Structure of Percutaneous Ventricular Assist Units
Figure 78. Channels of Distribution
Figure 79. Global Percutaneous Ventricular Assist Units Sales Market Forecast by Region (2027-2032)
Figure 80. Global Percutaneous Ventricular Assist Units Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Percutaneous Ventricular Assist Units Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Percutaneous Ventricular Assist Units Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Percutaneous Ventricular Assist Units Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Percutaneous Ventricular Assist Units Revenue Market Share Forecast by Application (2027-2032)